Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.37 | 8e-27 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-18 |
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.25 | 7e-18 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-14 |
mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-13 |
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-13 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-13 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.36 | 1e-12 |
mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-08 |
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-08 |